Naphthoquine phosphate and its combination with artemisinine

Acta Tropica

Volumn 89, Issue 3, 2004, Pages 375-381

  Wang, Jing Yan ^a   Cao, Wu Chun ^a   Shan, Cheng Qi ^a   Zhang, Min ^a   Li, Guo Fu ^a   Ding, De Ben ^a   Shi, Yun Lin ^a   Wu, Bo An ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Antimalarial; Artemisinin; Combination; Naphthoquine phosphate

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE; CONAPHTHOQUINE; NAPHTHOQUINE PHOSPHATE; UNCLASSIFIED DRUG;

MALARIA;

CLINICAL TRIAL; DOG; DOSE RESPONSE; DRUG DOSAGE FORM; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DRUG STRUCTURE; DRUG TOXICITY; HUMAN; LD 50; MALARIA; MONKEY; NONHUMAN; PATIENT COMPLIANCE; PLASMODIUM BERGHEI; PLASMODIUM KNOWLESI; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; TABLET; TREATMENT OUTCOME;

ANIMALIA;

EID: 1642565090     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2003.11.008     Document Type: Article

References (4)

1. Looareesuwan S., Harinasuta T., Chongsuphajaisiddhi T. Drug resistant malaria with special reference in Thailand. Southeast Asian J. Trop. Med. Public. Health23:1992;621-634.
2. White N.J. Assessment of the pharmacodytnamic properties of antimalarial drugs in vivo. Antimicrobial Agents Chemother. 41:1997;1413-1422.
3. Pang X., Wang G., Xing Q.et al. Hundred and one cases Plasmodium falciparum patients treated naphthoquine phosphate. Chin. J. Parasitol. Parasitic Dis. 17(1):1999;20.
4. Guo W., Zheng Q., Li G.et al. A randomized-controlled study of naphthoquine and artesunate in the treatment of falciparum malaria. J. Guangzhou Univ. Trad. Chin. Med. 17(3):2000;235-237.